Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT01980888 · TERMINATED
Trial details
- NCT number
- NCT01980888
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-05
- Primary completion
- 2016-05-30
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.